stockrowCytomX Therapeutics, Inc. (CTMX) vs MiMedx Group, Inc (MDXG)
- CytomX Therapeutics, Inc. CTMX 2.19 +2.34%
- MiMedx Group, Inc MDXG 3.31 +0.91%
CytomX Therapeutics, Inc. and MiMedx Group, Inc are both Biotechnology companies. CytomX Therapeutics, Inc. and MiMedx Group, Inc are of similar size ($478.6M and $466.3M). MiMedx Group, Inc grew revenue faster over the last twelve months: −22.8% against −87.7%. MiMedx Group, Inc has the higher net margin (−6.32% vs −630.4%) and the higher return on invested capital (−17.4% vs −20.8%). Across the 17 metrics below, MiMedx Group, Inc leads on 14 and CytomX Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | CTMX | MDXG | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 77.29% | 68.51% |
| Operating margin | (676.45%) | (8.28%) | 0.00% |
| Net margin | (630.38%) | (6.32%) | 0.00% |
| Free cash flow margin | (362.89%) | 6.26% | 0.00% |
| Return on equity | (45.08%) | (8.53%) | (51.96%) |
| Return on assets | (33.82%) | (6.58%) | (46.06%) |
| Return on invested capital | (20.82%) | (17.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack